The risk factors for herpes zoster in bortezomib treatment in patients with multiple myeloma

BACKGROUND: Bortezomib has significant activity in treating multiple myeloma (MM). The risk of herpes zoster (HZ) has been reported to increase significantly with bortezomib treatment, but the predisposing factors for HZ are not clear. This study is a retrospective analysis of the relevant risk fact...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Yi, Yang-Seon, Chung, Joo-Seop, Song, Moo-Kon, Shin, Ho-Jin, Seol, Young-Mi, Choi, Young-Jin, Cho, Goon-Jae, Lee, Gyeong-Won, Moon, Joon-Ho, Hwang, In-Hye, Ahn, Kang-Hee, Lee, Hee-Sun, Shin, Kyung-Hwa, Hwang, Jong-Min
Formato: Artigo
Idioma:Inglês
Publicado em: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2010
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2983043/
https://ncbi.nlm.nih.gov/pubmed/21120208
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5045/kjh.2010.45.3.188
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados